![]() |
市場調查報告書
商品編碼
1828142
2025年全球直線加速器設備市場報告LINAC Devices Global Market Report 2025 |
近年來,直線加速器市場規模強勁成長,從2024年的51億美元增加至2025年的54.8億美元,複合年成長率為7.4%。這段時期的成長得益於治療速度、標準化和監管的進步、放射線手術和立體定位放射線手術的發展、安全性能的增強以及影像整合的改進。
預計未來幾年直線加速器設備市場規模將強勁成長,到2029年將達到77.4億美元,複合年成長率為9.0%。預測期內的成長可歸因於癌症發病率的上升、自適應放射治療的發展、對影像導航放射治療(IGRT) 的需求不斷成長、安全性和患者舒適度的提升以及人工智慧 (AI) 的整合。預測期內的主要趨勢包括創新軟體解決方案、自適應放射治療的發展、遠端醫療整合、行為管理的融入以及對以患者為中心的護理的重視。
Linac 是直線加速器的縮寫,指的是一種用於直線加速電子和質子等帶電粒子的裝置。在醫療實踐中,直線加速器用於產生高能量電子束和 X光束,用於放射治療,尤其是癌症治療。
直線加速器主要分為高能、低能、中能三種。高能量線性加速器(LINAC) 的工作能量範圍為 2,000 萬至 5,000 萬電子伏特 (MeV)。它們用於產生高能量 X光和電子束,用於放射治療,特別適用於治療體內深層腫瘤。直線加速器和非專用直線加速器可用於治療多種癌症,包括乳癌、結腸癌、頭頸癌、肺癌和攝護腺癌。這些機器廣泛應用於診所、醫院和研究中心。
2025年春季,美國關稅飆升及其引發的貿易摩擦對醫療設備產業產生了重大影響,尤其對影像處理設備、手術用不銹鋼和一次性塑膠等進口零件產生了重大影響。由於醫院和診所抵制漲價,製造商面臨利潤壓力。監管挑戰使情況更加複雜,因為由於關稅而更換供應商通常需要醫療設備重新認證,導致市場准入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。
本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分,該系列提供直線加速器設備市場統計數據,例如全球市場規模、區域佔有率、直線加速器設備市場佔有率的競爭對手、詳細的直線加速器設備細分市場、市場趨勢以及直線加速器設備行業的商機。本直線加速器設備市場研究報告對該行業的現狀和未來趨勢進行了詳細分析,為您提供所需的一切觀點。
未來五年預測成長率為9.0%,較我們先前對該市場的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。這將透過對荷蘭和巴西等關鍵地區生產的微波發生器和多葉準直器徵收關稅直接影響美國,這可能導致癌症治療推遲,並增加放射治療設備的維護成本。此外,由於互惠關稅以及貿易緊張局勢和限制措施加劇對全球經濟和貿易的負面影響,這種影響也將更加廣泛地顯現。
癌症患者數量的預期成長將推動直線加速器設備市場的成長。癌症的特徵是細胞生長失控以及體內異常細胞的擴散,放射治療中使用直線加速器 (LINAC) 進行治療。這些機器將高能量X光從外部來源發射到癌症部位,以治療各種癌症。值得注意的是,根據美國癌症協會截至2023年1月的數據,預計癌症患者數量將從2021年的1,898,160人增加3.16%,到2023年將達到1,958,310人。因此,癌症患者數量的成長是推動直線加速器設備市場發展的關鍵因素。
不斷成長的醫療支出推動了直線加速器設備市場的成長。醫療支出是指特定時限內醫療產品和服務的總支出,包括使用直線加速器設備進行先進腫瘤治療的相關費用。例如,加拿大衛生資訊研究所 (CIHI) 於 2022 年 11 月發布的預測顯示,加拿大的醫療總支出將增加 0.8%,從 2021 年的 3,280 億美元增至 2022 年的 3,310 億美元。醫療支出的這種上升趨勢是直線加速器設備市場發展的驅動力。
技術進步正成為直線加速器設備市場的顯著趨勢,主要企業紛紛推出創新產品,例如ViewRay MRIdian MRI導引放射治療系統,以維持其市場地位。 2023年3月,美國癌症和心臟護理提供者GenesisCare在Lee Health Regional Cancer Center推出了MRI導引放射治療系統。 MRIdian系統將高精度放射治療與尖端高解析度MRI導引相結合,可望減少所需的治療次數。這項以MRIdian立體定位MRI引導自適應放射治療(SMART)為代表的技術創新,代表了直線加速器設備市場的重要趨勢。
直線加速器設備市場的主要參與者正專注於開發先進技術,例如基於人工智慧的自適應 CT-Linac 系統,以提高治療準確性、最佳化放射輸送並改善癌症治療中的患者預後。基於人工智慧的自我調整CT-Linac 是一種先進的放射治療系統,結合了電腦斷層掃描 (CT) 成像和直線加速器 (linac) 技術。它利用人工智慧即時調整治療計劃,提高精度並改善患者預後。例如,2024 年 5 月,總部位於瑞典的精準放射治療解決方案領導者 Elekta 推出了 Elekta Evo。這款最先進的直線加速器 (linac) 專為癌症治療而設計,擁有高清、人工智慧增強影像處理能力,可實現離線和線上自適應放射治療。這種靈活的系統使臨床醫生能夠根據每位患者的獨特需求選擇最有效的放射治療技術,從而提高標靶準確性並最大限度地減少副作用。 Evo 內建治療計畫自動化功能,可提高工作流程效率並促進放射腫瘤學的個人化治療。
2023年11月,荷蘭磁控管和晶閘管製造商AEP Linac與Arcare達成合作,以增強其放射治療解決方案,合作金額不詳。 AEP Linac是一家生產用於(醫用)直線加速器的磁控管和閘流管的製造商。此次合作旨在整合Arcare在患者照護產品方面的專業知識,並增強AEP Linac的產品線,最終改善整體治療體驗。 Arcare是一家總部位於日本的公司,以其創新的解決方案而聞名,這些解決方案優先考慮患者在醫療環境中的舒適度和復原力。
直線加速器設備市場的主要參與者包括 Accuracy Inc.、Elekta AB、GE Healthcare Technologies Inc.、Hitachi, Ltd.、Huiheng Medical Inc.、Koninklijke Philips NV、Mitsubishi Heavy Industries, Ltd.、Top Grade Healthcare Group、Varian Medical Systems Inc.、Siemens Healthine Healthine Gmb. GmbH、工業, Ltd.、ProNova Solutions LLC、RaySearch Laboratories AB、P-Cureapcm. Inc.、Nanobiotix SA、C-RAD AB、Theragenics Corporation、Isoray Inc. 和 Nordion Inc.
2024年,北美是直線加速器設備市場最大的地區。預計亞太地區將成為預測期內全球直線加速器設備市場成長最快的地區。直線加速器設備市場報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。
直線加速器設備市場報告涵蓋的國家包括澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利和西班牙
直線加速器設備市場包括電子生成組件、光束傳輸設備、放射治療設備以及成像和監測配件的銷售。該市場的價值指的是“出廠價”,即商品製造商或生產商銷售給其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。
LINAC stands for linear accelerator, and it refers to a device designed to accelerate charged particles, such as electrons or protons, in a straight line. In medical settings, LINACs are utilized to generate high-energy electron or X-ray beams for radiation therapy, specifically in the treatment of cancer.
The main products of LINAC devices include high-energy, low-energy, and medium-energy devices. A high-energy linear accelerator (LINAC) operates at energies ranging from 20 to 50 million electron volts (MeV). It is used to produce high-energy X-rays or electron beams for radiation therapy, particularly for treating tumors located deep within the body. Linear accelerator and non-dedicated linear accelerator methods are employed in the treatment of various cancers such as breast cancer, colorectal cancer, head and neck cancer, lung cancer, prostate cancer, and others. These devices find application in clinics, hospitals, and research centers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The LINAC devices market research report is one of a series of new reports from The Business Research Company that provides LINAC devices market statistics, including the LINAC devices industry global market size, regional shares, competitors with a LINAC devices market share, detailed LINAC devices market segments, market trends, and opportunities, and any further data you may need to thrive in the LINAC devices industry. This LINAC devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The linac devices market size has grown strongly in recent years. It will grow from $5.1 billion in 2024 to $5.48 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to advancements in treatment delivery speed, standardization and regulation, growth in radiosurgery and stereotactic radiosurgery, enhanced safety features, improvements in imaging integration.
The linac devices market size is expected to see strong growth in the next few years. It will grow to $7.74 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to rise in cancer incidences, development of adaptive radiotherapy, increasing demand for image-guided radiation therapy (IGRT), enhanced safety and patient comfort, integration of artificial intelligence (AI). Major trends in the forecast period include innovative software solutions, adaptive radiotherapy development, telemedicine integration, incorporation of motion management, focus on patient-centric care.
The forecast of 9.0% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on microwave power generators and multi-leaf collimators, sourced from key regions such as the Netherlands and Brazil, which could lead to postponed cancer treatments and increased costs for radiation therapy equipment maintenance.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The anticipated increase in cancer cases is set to drive the growth of the LINAC devices market. Cancer, characterized by uncontrolled cell growth and the spread of abnormal cells within the body, is a target for treatment using Linear Accelerators (LINAC) in radiation therapy. These devices deliver high-energy X-rays externally to the cancer site to treat various forms of cancer. Notably, data from the American Cancer Society in January 2023 indicates a rise in cancer cases from 1,898,160 in 2021 to 1,958,310 in 2023, marking a 3.16% growth. Consequently, the growing number of cancer cases is a significant factor propelling the LINAC devices market.
The increasing healthcare expenditure is poised to contribute to the growth of the LINAC devices market. Healthcare expenditure, representing the total financial outlay on healthcare goods and services within a specific timeframe, encompasses the costs associated with advanced oncology treatments using Linear Accelerator (LINAC) devices. For example, projections from the Canadian Institute for Health Information (CIHI) in November 2022 forecast a 0.8% increase in total health spending in Canada, from $328 billion in 2021 to $331 billion in 2022. This upward trend in healthcare expenditure is a driving force behind the LINAC devices market.
Technological advancements emerge as a prominent trend in the LINAC devices market, with major companies introducing innovative products such as the ViewRay MRIdian MRI-Guided Radiation Therapy System to maintain their market position. In March 2023, GenesisCare, a US-based provider of cancer and cardiac care, launched an MRI-guided radiation therapy system at the Lee Health Regional Cancer Center. The MRIdian system combines precision radiation therapy with state-of-the-art, high-resolution MRI guidance, potentially reducing the number of treatment sessions required. This technological innovation, exemplified by MRIdian Stereotactic MRI-guided Adaptive Radiotherapy (SMART) therapy, marks a significant trend in the LINAC devices market.
Key players in the LINAC devices market are focusing on the development of advanced technologies, including AI-powered adaptive CT-Linac systems, to improve treatment accuracy, optimize radiation delivery, and enhance patient outcomes in cancer therapy. An AI-powered adaptive CT-Linac is a sophisticated radiation therapy system that merges computed tomography (CT) imaging with linear accelerator (LINAC) technology, employing artificial intelligence to adjust treatment plans in real time for better precision and improved patient results. For example, in May 2024, Elekta, a Sweden-based leader in precision radiation therapy solutions, introduced Elekta Evo. This state-of-the-art linear accelerator (LINAC) is designed for cancer treatment and boasts high-definition AI-enhanced imaging capabilities, enabling both offline and online adaptive radiation therapy. The flexible system empowers clinicians to choose the most effective radiation therapy techniques tailored to each patient's unique needs, thereby enhancing targeting accuracy and minimizing side effects. With built-in automation for treatment planning, Evo improves workflow efficiency and promotes personalized care in radiation oncology.
In November 2023, AEP Linac, a Netherlands-based manufacturer of magnetrons and thyratrons utilized in (medical) linear accelerators, formed a partnership with Alcare for an undisclosed amount to strengthen its radiation therapy solutions. This collaboration aims to enhance AEP Linac's product offerings by integrating Alcare's expertise in patient care products, ultimately improving the overall treatment experience. Alcare is a Japan-based company known for its innovative solutions that prioritize patient comfort and recovery in medical environments.
Major companies operating in the LINAC devices market include Accuracy Inc., Elekta AB, GE Healthcare Technologies Inc., Hitachi Ltd., Huiheng Medical Inc., Koninklijke Philips N.V., Mitsubishi Heavy Industries Ltd., Top Grade Healthcare Group, Varian Medical Systems Inc., Siemens Healthineers GmbH, Shinva Medical Instrument Co. Ltd., Altair Technologies Inc., BEVATECH GmbH, CGN Dasheng Electron Accelerator Technology Company Limited, Diondo GmbH, IBA SA, Brainlab AG, Panacea Medical Technologies Pvt. Ltd., Viewray Technologies Inc., MeVion Medical Systems Inc., Sumitomo Heavy Industries Ltd., ProNova Solutions LLC, RaySearch Laboratories AB, P-Cure Ltd., Best Theratronics Ltd., Advanced Oncotherapy PLC, RefleXion Medical Inc., Nanobiotix S A, C-RAD AB, Theragenics Corporation, Isoray Inc., Nordion Inc.
North America was the largest region in the LINAC devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global LINAC devices market report during the forecast period. The regions covered in the linac devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the linac devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The LINAC devices market consists of sales of an electron generation component, beam transport equipment, radiotherapy equipment, imaging and monitoring accessory. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
LINAC Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on linac devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for linac devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The linac devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.